Transient receptor potential (TRP) channels and cardiac fibrosis

Current Topics in Medicinal Chemistry

Volumn 13, Issue 3, 2013, Pages 270-282

  Yue, Zhichao ^a   Zhang, Yanhui ^a   Xie, Jia ^a   Jiang, Jianmin ^a   Yue, Lixia ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Extracellular matrix; Fibroblasts; Fibrosis; Remodeling; TRP channels

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; CALCIUM ION; CLUSTERIN; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN; ION CHANNEL; LISINOPRIL; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7;

AGING; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONGESTIVE CARDIOMYOPATHY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; FIBROSIS; HEART ARRHYTHMIA; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; ISCHEMIC CARDIOMYOPATHY; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; FIBROSIS; HEART DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84876711469     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313030005     Document Type: Review

References (175)

1. Weber, K.T., Sun, Y. and Diez, J., Fibrosis: A Living Tissue and the Infarcted Heart. J Am Coll Cardiol., 2008, 52(24), 2029-2031.
2. de Bakker, J.M., van Capelle, F.J., Janse, M.J., Tasseron, S., Vermeulen, J.T., de Jonge, N. and Lahpor, J.R., Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol., 1996, 27(5), 1071-8.
3. Burstein, B. and Nattel, S., Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation. Journal of the American College of Cardiology. 2008, 51(8), 802-809.
4. Yue, L., Xie, J. and Nattel, S., Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res., 2011, 89(4), 744-53.
5. Khan, R. and Sheppard, R., Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology., 2006, 118(1), 10-24.
6. Weber, K.T., Are myocardial fibrosis and diastolic dysfunction reversible in hypertensive heart disease? Congest Heart Fail., 2005, 11(6), 322-4.
7. Kania, G., Blyszczuk, P. and Eriksson, U., Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med., 2009, 19(8), 247-52.
8. Biernacka, A. and Frangogiannis, N.G., Aging and Cardiac Fibrosis. Aging Dis., 2(2), 158-173.
9. Anderson, K.R., Sutton, M.G. and Lie, J.T., Histopathological types of cardiac fibrosis in myocardial disease. J Pathol., 1979, 128(2), 79-85.
10. Weber, K.T., Pick, R., Jalil, J.E., Janicki, J.S. and Carroll, E.P., Patterns of myocardial fibrosis. J Mol Cell Cardiol., 1989, 21 Suppl 5,121-31.
11. Isoyama, S. and Nitta-Komatsubara, Y., Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Fail Rev. 2002, (1), 63-9.
12. Swynghedauw, B., Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999, 79(1), 215-62.
13. Weber, K.T., Sun, Y., Tyagi, S.C. and Cleutjens, J.P., Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol., 1994, 26(3), 279-92.
14. Powell, D.W., Mifflin, R.C., Valentich, J.D., Crowe, S.E., Saada, J.I. and West, A.B., Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol., 1999, 277(1 Pt 1), C1-9.
15. Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R.A., Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol., 2002 3(5), 349-63.
16. Sun, Y. and Weber, K.T., Infarct scar: a dynamic tissue. Cardiovasc Res., 2000, 46(2), 250-6.
17. Petrov, V.V., Fagard, R.H. and Lijnen, P.J., Stimulation of Collagen Production by Transforming Growth Factor-{beta}1 During Differentiation of Cardiac Fibroblasts to Myofibroblasts. Hypertension. 2002, 39(2), 258-263.
18. Porter, K.E. and Turner, N.A., Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther., 2009, 123(2), 255-78.
19. Leask, A., Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res., 2012, 106(11), 1675-80.
20. Weber, K. Cardiac interstitium, in Heart Failure, P. Poole-Wilson, et al., Editors, Churchill Livingstone: New York, NY., 1997, 13-31.
21. Beltrami, C.A., Finato, N., Rocco, M., Feruglio, G.A., Puricelli, C., Cigola, E., Quaini, F., Sonnenblick, E.H., Olivetti, G. and Anversa, P., Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation., 1994, 89(1), 151-163.
22. Sun, Y., Kiani, M.F., Postlethwaite, A.E. and Weber, K.T., Infarct scar as living tissue. Basic Res Cardiol., 2002, 97(5), 343-7.
23. Brooks, A., Schinde, V., Bateman, A.C. and Gallagher, P.J. Interstitial fibrosis in the dilated non-ischaemic myocardium. Heart. 2003, 89(10), 1255-6.
24. Marijianowski, M.M., Teeling, P., Mann, J. and Becker, A.E., Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. J Am Coll Cardiol., 1995, 25(6), 1263-72.
25. Sanderson, J.E., Lai, K.B., Shum, I.O., Wei, S. and Chow, L.T., Transforming growth factor-beta(1) expression in dilated cardiomyopathy. Heart., 2001, 86(6), 701-8.
26. Kuhl, U., Noutsias, M. and Schultheiss, H.P., Immunohistochemistry in dilated cardiomyopathy. Eur Heart J., 1995, 16 Suppl O, 100-6.
27. Dixon, I.M., Hao, J., Reid, N.L. and Roth, J.C., Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc Res., 2000, 46(2): p. 286-97.
28. Kostin, S., Klein, G., Szalay, Z., Hein, S., Bauer, E.P. and Schaper, J., Structural correlate of atrial fibrillation in human patients. Cardiovasc Res., 2002, 54(2), 361-79.
29. Benjamin, E.J., Chen, P.-S., Bild, D.E., Mascette, A.M., Albert, C.M., Alonso, A., Calkins, H., Connolly, S.J., Curtis, A.B., Darbar, D., Ellinor, P.T., Go, A.S., Goldschlager, N.F., Heckbert, S.R., Jalife, J., Kerr, C.R., Levy, D., Lloyd-Jones, D.M., Massie, B.M., Nattel, S., Olgin, J.E., Packer, D.L., Po, S.S., Tsang, T.S.M., Van Wagoner, D.R., Waldo, A.L. and Wyse, D.G., Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop. Circulation., 2009, 119(4), 606-618.
30. Boldt, A., Wetzel, U., Lauschke, J., Weigl, J., Gummert, J., Hindricks, G., Kottkamp, H. and Dhein, S., Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart., 2004, 90(4), 400-5.
31. Xu, J., Cui, G., Esmailian, F., Plunkett, M., Marelli, D., Ardehali, A., Odim, J., Laks, H. and Sen, L., Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation., 2004, 109(3), 363-8.
32. Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M.A. and Maseri, A., Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation., 1997, 96(4), 1180-4.
33. Nakajima, H., Nakajima, H.O., Salcher, O., Dittie, A.S., Dembowsky, K., Jing, S. and Field, L.J. 2000, Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factorbeta(1) transgene in the heart. Circ Res., 2000, 86(5), 571-9.
34. Verheule, S., Sato, T., Everett, T.t., Engle, S.K., Otten, D., Rubartvon der Lohe, M., Nakajima, H.O., Nakajima, H., Field, L.J. and Olgin, J.E., Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res., 2004, 94(11), 1458-65.
35. Cha, T.J., Ehrlich, J.R., Zhang, L., Shi, Y.F., Tardif, J.C., Leung, T.K. and Nattel, S., Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation. 2004, 109(3), 412-8.
36. Shinagawa, K., Shi, Y.F., Tardif, J.C., Leung, T.K. and Nattel, S., Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation., 2002, 105(22), 2672-8.
37. Pearlman, E.S., Weber, K.T., Janicki, J.S., Pietra, G.G. and Fishman, A.P., Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest., 1992, 46(2), 158-64.
38. Rossi, M.A., Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens., 1998, 16(7), 1031-41.
39. Brilla, C.G., Janicki, J.S. and Weber, K.T., Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res., 1991, 69(1), 107-15.
40. Diez, J., Querejeta, R., Lopez, B., Gonzalez, A., Larman, M. and Martinez Ubago, J.L., Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation., 2002, 105(21), 2512-7.
41. Sugihara, N., Genda, A., Shimizu, M., Suematu, T., Kita, Y., Horita, Y. and Takeda, R., Quantitation of myocardial fibrosis and its relation to function in essential hypertension and hypertrophic cardiomyopathy. Clin Cardiol., 1988, 11(11), 771-8.
42. Sugihara, N., Genda, A., Shimizu, M., Suematsu, T., Kita, Y., Minamoto, M., Kawagoshi, H., Umeda, K., Chin, S. and Takeda, R., [Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension]. J Cardiol., 18(2), 353-61.
43. Brilla, C.G., Matsubara, L. and Weber, K.T., Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinoprilmediated regression of myocardial fibrosis. Hypertension., 1996, 28(2), 269-75.
44. Brilla, C.G., Janicki, J.S. and Weber, K.T., Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation., 1991, 83(5), 1771-9.
45. Sangaralingham, S.J., Huntley, B.K., Martin, F.L., McKie, P.M., Bellavia, D., Ichiki, T., Harders, G.E., Chen, H.H. and Burnett, J.C., The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide. Hypertension., 2011, 57(2),. 201-207.
46. Aharinejad, S., Krenn, K., Paulus, P., Schafer, R., Zuckermann, A., Grimm, M. and Abraham, D., Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant., 2005, 5(9), 2185-92.
47. Weber, K.T., Brilla, C.G. and Janicki, J.S., Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res., 1993, 27(3), 341-8.
48. Hanatani, A., Yoshiyama, M., Kim, S., Omura, T., Toda, I., Akioka, K., Teragaki, M., Takeuchi, K., Iwao, H. and Takeda, T., Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol., 1995, 27(9), 1905-14.
49. Urata, H., Boehm, K.D., Philip, A., Kinoshita, A., Gabrovsek, J., Bumpus, F.M. and Husain, A., Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest., 1993, 91(4), 1269-81.
50. Lijnen, P.J., Piccart, Y., Coenen, T. and Prihadi, J.S., Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts. J Hypertens., 2012, 30(10),1986-91.
51. Lijnen, P.J., van Pelt, J.F. and Fagard, R.H., Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther., 2012, 30(1), 1-8.
52. Clancy, R.M., Zheng, P., O'Mahony, M., Izmirly, P., Zavadil, J., Gardner, L. and Buyon, J.P., Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum., 2007, 56(12), 4120-31.
53. Aragno, M., Mastrocola, R., Alloatti, G., Vercellinatto, I., Bardini, P., Geuna, S., Catalano, M.G., Danni, O. and Boccuzzi, G. 2008, Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats. Endocrinology., 2008, 149(1), 380-388.
54. Weber, K.T., Brilla, C.G., Campbell, S.E., Guarda, E., Zhou, G. and Sriram, K., Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol., 1993, 88(Suppl 1), 107-24.
55. Holtz, J., Pathophysiology of heart failure and the reninangiotensinsystem. Basic Res Cardiol., 1993, 88,183-201.
56. Weber, K.T., Sun, Y., Katwa, L.C. and Cleutjens, J.P., Tissue repair and angiotensin II generated at sites of healing. Basic Res Cardiol., 1997, 92(2),75-8.
57. Schultz Jel, J., Witt, S.A., Glascock, B.J., Nieman, M.L., Reiser, P.J., Nix, S.L., Kimball, T.R. and Doetschman, T, TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest., 2002, 109(6),787-96.
58. Campbell, S.E. and Katwa, L.C., Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol., 1997, 29(7),1947-58.
59. Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Knoell, D.L., Feldman, D.S. and Elton, T.S., TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol., 2007, 293(3),L790-9.
60. Tharaux, P.-L., Chatziantoniou, C., Fakhouri, F. and Dussaule, J.-C., Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway. Hypertension. 36(3),330-336.
61. Massague, J., The transforming growth factor-beta family. Annu Rev Cell Biol., 1990,6, 597-641.
62. Agrotis, A., Kalinina, N. and Bobik, A., Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr Vasc Pharmacol., 2005, 3(1),55-61.
63. Lijnen, P.J., Petrov, V.V. and Fagard, R.H., Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab., 2000,71(1-2),418-35.
64. Pedrozo, H.A., Schwartz, Z., Gomez, R., Ornoy, A., Xin-Sheng, W., Dallas, S.L., Bonewald, L.F., Dean, D.D. and Boyan, B.D., Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1. J Cell Physiol., 1998, 177(2), 343-54.
65. Brand, T. and Schneider, M.D., The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol., 1995, 27(1),5-18.
66. de Boer, R.A., Pokharel, S., Flesch, M., van Kampen, D.A., Suurmeijer, A.J., Boomsma, F., van Gilst, W.H., van Veldhuisen, D.J. and Pinto, Y.M., Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J Mol Med (Berl)., 2004, 82(10), 678-87.
67. Leask, A. and Abraham, D.J., TGF-beta signaling and the fibrotic response. FASEB J., 2004, 18(7), 816-27.
68. Santander, C. and Brandan, E., Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal., 2006, 18(9), 1482-91.
69. Liu, S., Xu, S.W., Kennedy, L., Pala, D., Chen, Y., Eastwood, M., Carter, D.E., Black, C.M., Abraham, D.J. and Leask, A., FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. Mol Biol Cell., 2007, 18(6), 2169-78.
70. Thannickal, V.J., Lee, D.Y., White, E.S., Cui, Z., Larios, J.M., Chacon, R., Horowitz, J.C., Day, R.M. and Thomas, P.E., Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem., 2003, 278(14),12384-9.
71. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T. and Ishii, S., ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J Biol Chem., 1999, 274(13), 8949-57.
72. Zhang, D., Gaussin, V., Taffet, G.E., Belaguli, N.S., Yamada, M., Schwartz, R.J., Michael, L.H., Overbeek, P.A. and Schneider, M.D. 2000, TAK1 is activated in the myocardium after pressure overloadand is sufficient to provoke heart failure in transgenic mice. Nat Med., 2000, 6(5), 556-63.
73. Small, E.M., Thatcher, J.E., Sutherland, L.B., Kinoshita, H., Gerard, R.D., Richardson, J.A., Dimaio, J.M., Sadek, H., Kuwahara, K. and Olson, E.N., Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res., 2010, 107(2), 294-304.
74. Kagiyama, S., Matsumura, K., Goto, K., Otsubo, T. and Iida, M., Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. Regul Pept., 2010, 160(1-3), 133-9.
75. Hein, S., Arnon, E., Kostin, S., Schonburg, M., Elsasser, A., Polyakova, V., Bauer, E.P., Klovekorn, W.P. and Schaper, J., Progression from compensated hypertrophy to failure in the pressureoverloaded human heart: structural deterioration and compensatory mechanisms. Circulation., 2002, 107(7),984-91.
76. Shimizu, N., Yoshiyama, M., Takeuchi, K., Hanatani, A., Kim, S., Omura, T., Iwao, H. and Yoshikawa, J., Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats. Jpn Circ J., 1998, 62(6),436-42.
77. Clozel, M. and Salloukh, H., Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann Med., 2005, 37(1),2-12.
78. Teder, P. and Noble, P.W., A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol., 2000, 23(1),7-10.
79. Rubanyi, G.M. and Polokoff, M.A., Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev., 1994, 46(3),325-415.
80. Shi-wen, X., Kennedy, L., Renzoni, E.A., Bou-Gharios, G., du Bois, R.M., Black, C.M., Denton, C.P., Abraham, D.J. and Leask, A., Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum., 2007, 56(12),4189-94.
81. Shephard, P., Hinz, B., Smola-Hess, S., Meister, J.J., Krieg, T. and Smola, H., Dissecting the roles of endothelin, TGF-beta and GMCSF on myofibroblast differentiation by keratinocytes. Thromb Haemost., 2004, 92(2), 262-74.
82. Leask, A. and Abraham, D.J., All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci., 2006, 119(23), 4803-10.
83. Creemers, E.E. and Pinto, Y.M., Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res., 2011,89(2),265-72.
84. Chen, M.M., Lam, A., Abraham, J.A., Schreiner, G.F. and Joly, A.H., CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol., 2000, 32(10),1805-19.
85. Perrot, A., Hussein, S., Ruppert, V., Schmidt, H.H., Wehnert, M.S., Duong, N.T., Posch, M.G., Panek, A., Dietz, R., Kindermann, I., Bohm, M., Michalewska-Wludarczyk, A., Richter, A., Maisch, B., Pankuweit, S. and Ozcelik, C., Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol., 2009, 104(1),90-9.
86. Leask, A., Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal., 2008, 20(8),1409-14.
87. Shi-Wen, X., Leask, A. and Abraham, D., Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev.,2008,19(2),133-44.
88. Hayata, N., Fujio, Y., Yamamoto, Y., Iwakura, T., Obana, M., Takai, M., Mohri, T., Nonen, S., Maeda, M. and Azuma, J., Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun., 2008, 370(2),274-8.
89. Kennedy, L., Liu, S., Shi-Wen, X., Chen, Y., Eastwood, M., Sabetkar, M., Carter, D.E., Lyons, K.M., Black, C.M., Abraham, D.J. and Leask, A., CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res., 313(5), 952-64.
90. Panek, A.N., Posch, M.G., Alenina, N., Ghadge, S.K., Erdmann, B., Popova, E., Perrot, A., Geier, C., Dietz, R., Morano, I., Bader, M. and Ozcelik, C., Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One., 2009, 4(8),6743.
91. Bonner, J.C., Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev, 2004, 15(4),255-73.
92. Trengove, N.J., Bielefeldt-Ohmann, H. and Stacey, M.C., Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen., 2000, 8(1),13-25.
93. Heldin, C.H. and Westermark, B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev., 1999, 79(4),1283-316.
94. Uutela, M., Wirzenius, M., Paavonen, K., Rajantie, I., He, Y., Karpanen, T., Lohela, M., Wiig, H., Salven, P., Pajusola, K., Eriksson, U. and Alitalo, K., PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood., 2004, 104(10),3198-204.
95. Ihn, H., Yamane, K., Asano, Y., Jinnin, M. and Tamaki, K., Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Rheumatology (Oxford)., 2006, 45(2),157-65.
96. Jinnin, M., Ihn, H., Mimura, Y., Asano, Y., Yamane, K. and Tamaki, K., Regulation of fibrogenic/fibrolytic genes by plateletderived growth factor C, a novel growth factor, in human dermal fibroblasts. J Cell Physiol., 2005, 202(2),510-7.
97. Ponten, A., Folestad, E.B., Pietras, K. and Eriksson, U., Plateletderived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res., 2005, 97(10),1036-45.
98. Ponten, A., Li, X., Thoren, P., Aase, K., Sjoblom, T., Ostman, A. and Eriksson, U., Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol., 2003, 163(2),673-82.
99. Liao, C.H., Akazawa, H., Tamagawa, M., Ito, K., Yasuda, N., Kudo, Y., Yamamoto, R., Ozasa, Y., Fujimoto, M., Wang, P., Nakauchi, H., Nakaya, H. and Komuro, I., Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressureoverloaded mouse hearts. J Clin Invest., 2010, 120(1),242-53.
100. Burstein, B., Libby, E., Calderone, A. and Nattel, S., Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences. Circulation., 2008,117(13),1630-1641.
101. Snider, P., Standley, K.N., Wang, J., Azhar, M., Doetschman, T. and Conway, S.J., Origin of Cardiac Fibroblasts and the Role of Periostin. Circulation Research., 2009, 105(10),934-947.
102. Krenning, G., Zeisberg, E.M. and Kalluri, R., The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol., 2010, 225(3),631-7.
103. Kamkin, A., Kiseleva, I., Wagner, K.D., Pylaev, A., Leiterer, K.P., Theres, H., Scholz, H., Gunther, J. and Isenberg, G., A possible role for atrial fibroblasts in postinfarction bradycardia. Am J Physiol Heart Circ Physiol., 2002, 282(3),842-9.
104. Kamkin, A., Kiseleva, I., Wagner, K.D., Lammerich, A., Bohm, J., Persson, P.B. and Gunther, J., Mechanically induced potentials in fibroblasts from human right atrium. Exp Physiol., 1999, 84(2),347-56.
105. Kamkin, A., Kiseleva, I. and Isenberg, G., Activation and inactivation of a non-selective cation conductance by local mechanical deformation of acutely isolated cardiac fibroblasts. Cardiovasc Res., 2003, 57(3),793-803.
106. Chilton, L., Ohya, S., Freed, D., George, E., Drobic, V., Shibukawa, Y., MacCannell, K.A., Imaizumi, Y., Clark, R.B., Dixon, I.M.C. and Giles, W.R., K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol., 2005, 288(6),2931-2939.
107. Shibukawa, Y., Chilton, E.L., Maccannell, K.A., Clark, R.B. and Giles, W.R., K+ currents activated by depolarization in cardiac fibroblasts. Biophys J., 2005, 88(6),3924-35.
108. Walsh, K.B. and Zhang, J., Neonatal rat cardiac fibroblasts express three types of voltage-gated K+ channels: regulation of a transient outward current by protein kinasec. Am J Physiol Heart Circ Physiol., 2008, 294(2),1010-1017.
109. Li, G.R., Sun, H.Y., Chen, J.B., Zhou, Y., Tse, H.F. and Lau, C.P., Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS One., 2009, 4(10),7307.
110. Chatelier, A., Mercier, A., Tremblier, B., Theriault, O., Moubarak, M., Benamer, N., Corbi, P., Bois, P., Chahine, M. and Faivre, J.F., A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts. The Journal of Physiology., 2012, 590(17),4307-4319.
111. Benamer, N., Fares, N., Bois, P. and Faivre, J.F., Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. Biochem Biophys Res Commun., 2011, 408(1),6-11.
112. Benamer, N., Moha Ou Maati, H., Demolombe, S., Cantereau, A., Delwail, A., Bois, P., Bescond, J. and Faivre, J.F., Molecular and functional characterization of a new potassium conductance in mouse ventricular fibroblasts. J Mol Cell Cardiol., 2009, 46(4),508-17.
113. El Chemaly, A., Guinamard, R., Demion, M., Fares, N., Jebara, V., Faivre, J.F. and Bois, P., A voltage-activated proton current in human cardiac fibroblasts. Biochem Biophys Res Commun., 2006, 340(2),512-6.
114. He, M.L., Liu, W.J., Sun, H.Y., Wu, W., Liu, J., Tse, H.F., Lau, C.P. and Li, G.R., Effects of ion channels on proliferation in cultured human cardiac fibroblasts. J Mol Cell Cardiol., 2011, 51(2),198-206.
115. Berridge, M.J., Bootman, M.D. and Roderick, H.L., Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol., 2013, 4(7), 517-29.
116. Oh-hora, M. and Rao, A., Calcium signaling in lymphocytes. Curr Opin Immunol., 2008, 20(3),250-8.
117. Kiseleva, I., Kamkin, A., Kohl, P. and Lab, M.J., Calcium and mechanically induced potentials in fibroblasts of rat atrium. Cardiovasc Res., 1996, 32(1),98-111.
118. Kiseleva, I., Kamkin, A., Pylaev, A., Kondratjev, D., Leiterer, K.P., Theres, H., Wagner, K.D., Persson, P.B. and Gunther, J., Electrophysiological properties of mechanosensitive atrial fibroblasts from chronic infarcted rat heart. J Mol Cell Cardiol., 1998, 30(6),1083-93.
119. Kumaran, C. and Shivakumar, K., Calcium-and superoxide anionmediated mitogenic action of substance P on cardiac fibroblasts. Am J Physiol Heart Circ Physiol., 2002, 282(5),1855-62.
120. Shivakumar, K. and Kumaran, C., L-type calcium channel blockers and EGTA enhance superoxide production in cardiac fibroblasts. J Mol Cell Cardiol., 2001, 33(2), 373-7.
121. Colston, J.T., Chandrasekar, B. and Freeman, G.L., A novel peroxideinduced calcium transient regulates interleukin-6 expression in cardiac-derived fibroblasts. J Biol Chem., 2002, 277(26), 23477-83.
122. Ramires, F.J., Sun, Y. and Weber, K.T., Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J Mol Cell Cardiol., 1998, 30(3), 475-83.
123. 2+ activity in human cardiac fibroblasts. J Cell Physiol., 2010, 223(1),68-75.
124. Montell, C., Jones, K., Hafen, E. and Rubin, G., Rescue of the Drosophila phototransduction mutation trp by germline transformation. Science., 1985, 230(4729),1040-3.
125. Montell, C. and Rubin, G.M., Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron., 1989, 2(4),1313-23.
126. Clapham, D.E., TRP channels as cellular sensors. Nature., 2003, 426(6966),517-24.
127. Montell, C., The TRP superfamily of cation channels. Sci STKE. 2005,(272),1-24.
128. Nilius, B. and Vennekens, R., From cardiac cation channels to the molecular dissection of the transient receptor potential channel TRPM4. Pflugers Arch., 2006, 453(3),313-21.
129. Hofmann, T., Obukhov, A.G., Schaefer, M., Harteneck, C., Gudermann, T. and Schultz, G., Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature., 1999, 397(6716),259-63.
130. Hofmann, T., Schaefer, M., Schultz, G. and Gudermann, T., Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA, 2002, 99(11),7461-6.
131. Dong, X.P., Wang, X. and Xu, H., TRP channels of intracellular membranes. J Neurochem., 2010, 113(2),313-28.
132. Yue, L., Peng, J.B., Hediger, M.A. and Clapham, D.E., CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature., 2001, 410(6829),705-9.
133. 2+ channel. J Biol Chem., 2001, 276(2),1020-5.
134. Nilius, B., Owsianik, G. and Voets, T., Transient receptor potential channels meet phosphoinositides. EMBO J., 2008, 27(21), 2809-16.
135. 2+) release channels in the endolysosome. Nat Commun. 1: p. 38.
136. Xie, J., Sun, B., Du, J., Yang, W., Chen, H.-C., Overton, J.D., Runnels, L.W. and Yue, L., Phosphatidylinositol 4,5-bisphosphate (PIP2) controls magnesium gatekeeper TRPM6 activity. Sci. Rep., 2011, 1,12.
137. Tóth, B. and Csanády, L., Pore collapse underlies irreversible inactivation of TRPM2 cation channel currents. Proceedings of the National Academy of Sciences., 2012,109(33), 13440-13445.
138. Watanabe, H., Murakami, M., Ohba, T., Takahashi, Y. and Ito, H., TRP channel and cardiovascular disease. Pharmacol Ther., 2008, 118(3),337-51.
139. 2+ Influx and Expression of TRPC Genes in Mouse Sinoatrial Node. Circ Res., 2007, 100(11),1605-1614.
140. Rose, R.A., Hatano, N., Ohya, S., Imaizumi, Y. and Giles, W.R., C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptormediated signalling. J Physiol., 2007, 580(1) 255-74.
141. Nishida, M., Onohara, N., Sato, Y., Suda, R., Ogushi, M., Tanabe, S., Inoue, R., Mori, Y. and Kurose, H., Galpha12/13-mediated upregulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J Biol Chem., 2007, 282(32), 23117-28.
142. 2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res., 2010, 106(5),992-1003.
143. Runnels, L.W., Yue, L. and Clapham, D.E., The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol., 2002, 4(5), 329-36.
144. Harada, M., Luo, X., Qi, X.Y., Tadevosyan, A., Maguy, A., Ordog, B., Ledoux, J., Kato, T., Naud, P., Voigt, N., Shi, Y., Kamiya, K., Murohara, T., Kodama, I., Tardif, J.-C., Schotten, U., Van Wagoner, D.R., Dobrev, D. and Nattel, S., TRPC3-Dependent Fibroblast Regulation in Atrial Fibrillation. Circulation., 2012, 126(17),2051-64.
145. Takahashi, K., Sakamoto, K. and Kimura, J., Hypoxic stress induces transient receptor potential melastatin 2 (TRPM2) channel expression in adult rat cardiac fibroblasts. J Pharmacol Sci., 2012, 118(2),186-97.
146. Hatano, N., Itoh, Y. and Muraki, K., Cardiac fibroblasts have functional TRPV4 activated by 4alpha-phorbol 12,13-didecanoate. Life Sci., 2009, 85(23-26),808-14.
147. Nadler, M.J., Hermosura, M.C., Inabe, K., Perraud, A.L., Zhu, Q., Stokes, A.J., Kurosaki, T., Kinet, J.P., Penner, R., Scharenberg, A.M. and Fleig, A., LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature, 2001, 411(6837), 590-5.
148. Runnels, L.W., Yue, L. and Clapham, D.E., TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science., 2001, 291(5506),1043-7.
149. Yamaguchi, H., Matsushita, M., Nairn, A.C. and Kuriyan, J., Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell., 2001, 7(5),1047-57.
150. Jiang, J., Li, M. and Yue, L., Potentiation of TRPM7 Inward Currents by Protons. J. Gen. Physiol., 2005, 126(2),137-50.
151. 2+ Permeability and pH Sensitivity in TRPM6 and TRPM7. J. Biol. Chem., 2007, 282(35),25817-25830.
152. 2+ homeostasis. Science., 2008, 322(5902),756-60.
153. 2+) homeostasis in mammals. Nat Commun., 2010, 1, 109.
154. Jin, J., Wu, L.-J., Jun, J., Cheng, X., Xu, H., Andrews, N.C. and Clapham, D.E., The channel kinase, TRPM7, is required for early embryonic development. Proceedings of the National Academy of Sciences., 2011.
155. Liu, W., Su, L.T., Khadka, D.K., Mezzacappa, C., Komiya, Y., Sato, A., Habas, R. and Runnels, L.W., TRPM7 regulates gastrulation during vertebrate embryogenesis. Dev Biol., 2011, 350(2), 348-57.
156. Aarts, M., Iihara, K., Wei, W.L., Xiong, Z.G., Arundine, M., Cerwinski, W., MacDonald, J.F. and Tymianski, M., A key role for TRPM7 channels in anoxic neuronal death. Cell., 2003,115(7),863-77.
157. Sun, H.S., Jackson, M.F., Martin, L.J., Jansen, K., Teves, L., Cui, H., Kiyonaka, S., Mori, Y., Jones, M., Forder, J.P., Golde, T.E., Orser, B.A., Macdonald, J.F. and Tymianski, M., Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci., 2009, 12(10),1300-7.
158. 2+ homeostasis by TRPM7. Cell., 2003, 114(2),191-200.
159. Desai, B.N., Krapivinsky, G., Navarro, B., Krapivinsky, L., Carter, B.C., Febvay, S., Delling, M., Penumaka, A., Ramsey, I.S., Manasian Y. and Clapham, D.E., Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev Cell., 2012, 22(6),1149-62.
160. Wei, C., Wang, X., Chen, M., Ouyang, K., Song, L.S. and Cheng, H., Calcium flickers steer cell migration. Nature., 2009, 457(7231),901-5.
161. Middelbeek, J., Kuipers, A.J., Henneman, L., Visser, D., Eidhof, I., van Horssen, R., Wieringa, B., Canisius, S.V., Zwart, W., Wessels, L.F., Sweep, F.C., Bult, P., Span, P.N., van Leeuwen, F.N. and Jalink, K., TRPM7 Is Required for Breast Tumor Cell Metastasis. Cancer Res., 2012.
162. 2+) inhibited channel and kinase. Adv Exp Med Biol., 704,173-83.
163. Sahni, J., Tamura, R., Sweet, I.R. and Scharenberg, A.M., TRPM7 regulates quiescent/proliferative metabolic transitions in lymphocytes. Cell Cycle., 2010,9(17), 3565-74.
164. McNeill, M.S., Paulsen, J., Bonde, G., Burnight, E., Hsu, M.Y. and Cornell, R.A., Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis. J Invest Dermatol., 2007,127(8),2020-30.
165. Elizondo, M.R., Arduini, B.L., Paulsen, J., MacDonald, E.L., Sabel, J.L., Henion, P.D., Cornell, R.A. and Parichy, D.M., Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr Biol., 2005, 15(7),667-71.
166. Zhang, Y.H., Sun, H.Y., Chen, K.H., Du, X.L., Liu, B., Cheng, L.C., Li, X., Jin, M.W. and Li, G.R., Evidence for functional expression of TRPM7 channels in human atrial myocytes. Basic Res Cardiol., 2012, 107(5),282.
167. Nishida, M. and Kurose, H., Roles of TRP channels in the development of cardiac hypertrophy. Naunyn Schmiedebergs Arch Pharmacol., 2008, 378(4),395-406.
168. 2+ channel mediating angiotensin II-induced myocardial apoptosis. Mol Cell Biochem.,2007,294(1-2),205-15.
169. Eder, P. and Molkentin, J.D., TRPC channels as effectors of cardiac hypertrophy. Circ Res., 2011, 108(2),265-72.
170. Kuwahara, K., Wang, Y., McAnally, J., Richardson, J.A., Bassel-Duby, R., Hill, J.A. and Olson, E.N., TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest., 2006,116(12),3114-26.
171. Wu, X., Eder, P., Chang, B. and Molkentin, J.D. 2010, TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proceedings of the National Academy of Sciences., 2010, 107(15),7000-7005.
172. Onohara, N., Nishida, M., Inoue, R., Kobayashi, H., Sumimoto, H., Sato, Y., Mori, Y., Nagao, T. and Kurose, H., TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J., 2006, 25(22),5305-16.
173. Heineke, J. and Molkentin, J.D., Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol., 2006, 7(8),589-600.
174. Shiroshita-Takeshita, A., Brundel, B.J., Burstein, B., Leung, T.K., Mitamura, H., Ogawa, S. and Nattel, S., Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res., 2007, 74(1),75-84.
175. Lee, K.W., Everett, T.H., Rahmutula, D., Guerra, J.M., Wilson, E., Ding, C. and Olgin, J.E., Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure. Circulation., 2006, 114(16),1703-1712.